Literature DB >> 17360237

Plasmodium vivax in Africa: hidden in plain sight?

Ronald Rosenberg1.   

Abstract

People who live in tropical Africa, south of the Sahara, are predominantly negative for the Duffy blood-group antigen, which mediates invasion of reticulocytes by Plasmodium vivax. Recent reports of a parasite that was molecularly diagnosed as P. vivax from populations who are suspected, or known, to be Duffy negative confound a large body of evidence that states that invasion of P. vivax requires the Duffy antigen. If confirmed, one of several possible explanations is that P. vivax, which originated in Asia, is now evolving to exploit alternate invasion receptors in Africa.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17360237     DOI: 10.1016/j.pt.2007.02.009

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  42 in total

1.  A recombinant dromedary antibody fragment (VHH or nanobody) directed against human Duffy antigen receptor for chemokines.

Authors:  Dorota Smolarek; Claude Hattab; Gholamreza Hassanzadeh-Ghassabeh; Sylvie Cochet; Carlos Gutiérrez; Alexandre G de Brevern; Rachanee Udomsangpetch; Julien Picot; Magdalena Grodecka; Kazimiera Wasniowska; Serge Muyldermans; Yves Colin; Caroline Le Van Kim; Marcin Czerwinski; Olivier Bertrand
Journal:  Cell Mol Life Sci       Date:  2010-05-11       Impact factor: 9.261

Review 2.  In silico studies on DARC.

Authors:  Alexandre G de Brevern; Ludovic Autin; Yves Colin; Olivier Bertrand; Catherine Etchebest
Journal:  Infect Disord Drug Targets       Date:  2009-06

3.  Using mitochondrial genome sequences to track the origin of imported Plasmodium vivax infections diagnosed in the United States.

Authors:  Priscila T Rodrigues; João Marcelo P Alves; Ana María Santamaria; José E Calzada; Maniphet Xayavong; Monica Parise; Alexandre J da Silva; Marcelo U Ferreira
Journal:  Am J Trop Med Hyg       Date:  2014-03-17       Impact factor: 2.345

4.  Higher Complexity of Infection and Genetic Diversity of Plasmodium vivax Than Plasmodium falciparum Across All Malaria Transmission Zones of Papua New Guinea.

Authors:  Abebe A Fola; G L Abby Harrison; Mita Hapsari Hazairin; Céline Barnadas; Manuel W Hetzel; Jonah Iga; Peter M Siba; Ivo Mueller; Alyssa E Barry
Journal:  Am J Trop Med Hyg       Date:  2017-04-06       Impact factor: 2.345

5.  Evaluation of Immunoglobulin G Responses to Plasmodium falciparum and Plasmodium vivax in Malian School Children Using Multiplex Bead Assay.

Authors:  Eric Rogier; Delynn M Moss; Anna N Chard; Victoria Trinies; Seydou Doumbia; Matthew C Freeman; Patrick J Lammie
Journal:  Am J Trop Med Hyg       Date:  2016-11-28       Impact factor: 2.345

6.  Novel potent metallocenes against liver stage malaria.

Authors:  Joana Matos; Filipa P da Cruz; Élia Cabrita; Jiri Gut; Fátima Nogueira; Virgílio E do Rosário; Rui Moreira; Philip J Rosenthal; Miguel Prudêncio; Paula Gomes
Journal:  Antimicrob Agents Chemother       Date:  2011-12-12       Impact factor: 5.191

Review 7.  Red blood cell polymorphism and susceptibility to Plasmodium vivax.

Authors:  Peter A Zimmerman; Marcelo U Ferreira; Rosalind E Howes; Odile Mercereau-Puijalon
Journal:  Adv Parasitol       Date:  2013       Impact factor: 3.870

8.  Estimating the global clinical burden of Plasmodium falciparum malaria in 2007.

Authors:  Simon I Hay; Emelda A Okiro; Peter W Gething; Anand P Patil; Andrew J Tatem; Carlos A Guerra; Robert W Snow
Journal:  PLoS Med       Date:  2010-06-15       Impact factor: 11.069

9.  The international limits and population at risk of Plasmodium vivax transmission in 2009.

Authors:  Carlos A Guerra; Rosalind E Howes; Anand P Patil; Peter W Gething; Thomas P Van Boeckel; William H Temperley; Caroline W Kabaria; Andrew J Tatem; Bui H Manh; Iqbal R F Elyazar; J Kevin Baird; Robert W Snow; Simon I Hay
Journal:  PLoS Negl Trop Dis       Date:  2010-08-03

10.  Y chromosome diversity, human expansion, drift, and cultural evolution.

Authors:  Jacques Chiaroni; Peter A Underhill; Luca L Cavalli-Sforza
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.